VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,357,000 | +29.7% | 58,400 | -11.1% | 2.48% | +34.4% |
| Q1 2018 | $1,046,000 | -36.8% | 65,700 | -17.6% | 1.85% | +17.1% |
| Q4 2017 | $1,656,000 | +93.5% | 79,700 | +33.5% | 1.58% | +136.9% |
| Q3 2017 | $856,000 | -71.7% | 59,700 | -65.9% | 0.67% | -67.6% |
| Q2 2017 | $3,028,000 | +272.0% | 175,000 | +137.1% | 2.05% | +233.8% |
| Q1 2017 | $814,000 | -32.7% | 73,800 | -9.9% | 0.62% | -1.1% |
| Q4 2016 | $1,210,000 | -47.5% | 81,900 | -12.8% | 0.62% | -67.0% |
| Q3 2016 | $2,305,000 | +39.4% | 93,900 | +14.4% | 1.89% | +23.3% |
| Q2 2016 | $1,653,000 | -24.7% | 82,100 | +1.2% | 1.53% | +653.2% |
| Q1 2016 | $2,195,000 | – | 81,100 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |